Cristina Suárez

8PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.

Francesca Jackson-Spence, James Larkin, Poulam Patel

|Mar 05, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma.

Sumanta K Pal, Alice Bernard-Tessier, Peter Grell

|Feb 26, 2025
STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinoma.

Sumanta K Pal, Thomas Powles, Ravindran Kanesvaran

|Feb 18, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.

Sumanta K Pal, Yohann Loriot, Andrea Necchi

|May 23, 2020
Latest progress in molecular biology and treatment in genitourinary tumours.

A González-Del-Alba, J Á Arranz, J Bellmunt

Pageof 2